Cargando…
The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report
INTRODUCTION: Recent consensus defines four SCLC subtypes on the basis of transcription factor expression: ASCL1, NEUROD1, POU2F3, and YAP1. The rare YAP1 subtype is associated with “neuroendocrine (NE)-low” cells among SCLC cell lines and patient samples. We evaluated YAP1 in 39 patients with pheno...
Autores principales: | Pearsall, Sarah M., Humphrey, Sam, Revill, Mitchell, Morgan, Derrick, Frese, Kristopher K., Galvin, Melanie, Kerr, Alastair, Carter, Mathew, Priest, Lynsey, Blackhall, Fiona, Simpson, Kathryn L., Dive, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718082/ https://www.ncbi.nlm.nih.gov/pubmed/32721553 http://dx.doi.org/10.1016/j.jtho.2020.07.008 |
Ejemplares similares
-
The Challenge for a European Network of Biobanks for Rare Diseases Taken up by RD-Connect
por: Monaco, Lucia, et al.
Publicado: (2015) -
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry
por: Pearsall, Sarah M., et al.
Publicado: (2023) -
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer
por: Schenk, Maximilian W., et al.
Publicado: (2021) -
Prostate adenocarcinoma of secretory type with wide expression of p63 and negativity of the basal marker Ck5/6: Rare subtype of adenocarcinoma of secretory origin and to be differentiated from basal cell carcinoma. Review of literature
por: M, Abbas, et al.
Publicado: (2020) -
Targeting subtype in ALL
por: von Stackelberg, Arend
Publicado: (2019)